[HTML][HTML] Diagnostic stewardship in infectious diseases: a continuum of antimicrobial stewardship in the fight against antimicrobial resistance

J Zakhour, SF Haddad, A Kerbage, H Wertheim… - International journal of …, 2023 - Elsevier
Antimicrobial resistance (AMR) has been exacerbated by the inappropriate use of
diagnostics, leading to excessive prescription of antimicrobials, and is an imminent threat to …

[HTML][HTML] Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated …

X Yang, X Li, S Qiu, C Liu, S Chen, H **a, Y Zeng… - Journal of Infection, 2024 - Elsevier
Objectives The COVID-19 pandemic has posed a significant threat to the global healthcare
system, presenting a major challenge to antimicrobial stewardship worldwide. Methods We …

[HTML][HTML] The battle against fungi: lessons in antifungal stewardship from COVID 19 times

SS Kanj, SF Haddad, JF Meis, PE Verweij… - International journal of …, 2023 - Elsevier
The COVID-19 pandemic has highlighted the detrimental effect of secondary pathogens in
patients with a primary viral insult. In addition to superinfections with bacterial pathogens …

COVID‐19‐associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID‐19 patients

J Calderón‐Parra, P Mills‐Sanchez… - Mycoses, 2022 - Wiley Online Library
Background COVID‐19‐associated pulmonary aspergillosis (CAPA) is a major complication
of critically ill COVID‐19 patients, with a high mortality rate and potentially preventable …

[HTML][HTML] Challenges to antimicrobial stewardship in the countries of the Arab League: Concerns of worsening resistance during the COVID-19 pandemic and proposed …

NA Rizk, R Moghnieh, N Haddad, MC Rebeiz… - Antibiotics, 2021 - mdpi.com
The COVID-19 pandemic is expected to worsen the global problem of antimicrobial
resistance (AMR). There is a heightened interest in understanding this effect and to develop …

Bacterial community-and hospital-acquired pneumonia in patients with critical covid-19—a prospective monocentric cohort study

L Doubravská, M Htoutou Sedláková, K Fišerová… - Antibiotics, 2024 - mdpi.com
The impact of bacterial pneumonia on patients with COVID-19 infection remains unclear.
This prospective observational monocentric cohort study aims to determine the incidence of …

Optimizing bacteriophage treatment of resistant Pseudomonas

L Ulrich, LX Steiner, C Giez, T Lachnit - Msphere, 2024 - journals.asm.org
Phage therapy is increasing in relevance as an alternative treatment to combat antibiotic
resistant bacteria. Phage cocktails are the state-of-the-art method of administering phages in …

A multicenter comparison of prevalence and predictors of antimicrobial resistance in hospitalized patients before and during the severe acute respiratory syndrome …

KA Bauer, LA Puzniak, KC Yu, KP Klinker… - Open Forum …, 2022 - academic.oup.com
Background Antibacterial therapy is frequently used in patients with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) without evidence of bacterial infection, prompting …

SARS-CoV-2–Legionella co-infections: a systematic review and meta-analysis (2020–2021)

M Riccò, P Ferraro, S Peruzzi, A Zaniboni, S Ranzieri - Microorganisms, 2022 - mdpi.com
Legionnaires' Disease (LD) is a severe, sometimes fatal interstitial pneumonia due to
Legionella pneumophila. Since the inception of the SARS-CoV-2 pandemic, some …

Antibiotic Usage in the COVID-19 Intensive Care Unit of an Infectious Diseases Hospital from Nord-Eastern Romania

A Vâţă, FM Roşu, OS Dorneanu, AE Lehaci, Ş Luca… - Medicina, 2023 - mdpi.com
Background and Objectives. The intensive care unit (ICU), especially in an infectious
disease hospital, is both an area with a high consumption of antibiotics (atb) and a …